No results for ‘’
Concord Biotech Ltd
NSE: CONCORDBIO BSE: 543960
₹1051.20
(4.40%)
Mon, 01 Jun 2026, 06:03 pm
Market Cap109.73B
PE Ratio42.20
Dividend1.02
Concord Biotech Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 616952 | 1217.94 | 25 Feb 2026 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 616952 | 1218.58 | 25 Feb 2026 |
| UBS PRINCIPAL CAPITAL ASIA LIMITED | bulk | Sell | 740159 | 2589.86 | 20 Sept 2024 |
| THE VANGUARD GROUP INC A/C VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNAT | bulk | Buy | 577183 | 2596.08 | 20 Sept 2024 |
| THE VANGUARD GROUP INC A/C VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | bulk | Buy | 697936 | 2596.08 | 20 Sept 2024 |
| NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | bulk | Buy | 600000 | 1386.95 | 28 May 2024 |
| 1575773 ONTARIO INC | bulk | Sell | 3548211 | 1361.26 | 28 May 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 153421 | 1421.7 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Buy | 153421 | 1421.7 | 25 Jan 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 735455 | 935.17 | 18 Aug 2023 |
Showing 1–10 of 14
Rows per page: